Capozzi Heidi B's Form 4 filing
CVS Health Corp (CVS) · filed Oct 14, 2025
- Accession no.
- 0000064803-25-000031
- Filed
- Oct 14, 2025
- Trade date
- Sep 9-Oct 23, 2024
- Filing delay
- 400 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $4.59K. It was filed 400 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Capozzi Heidi BCIK 0001661608 | Officer (EVP and Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | Common Stock | PPurchaseAcquired | +35 | $56.47 | +$1,976.45 | 40 | Indirect | |
| Oct 2, 2024 | Common Stock | PPurchaseAcquired | +10 | $62.24 | +$622.4 | 50 | Indirect | |
| Oct 23, 2024 | Common Stock | PPurchaseAcquired | +35 | $56.85 | +$1,989.75 | 85 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.